Skip to content
Almac Group logo — A unique culture delivering exceptional solutions

Almac Group

A unique culture delivering exceptional solutions

Founded 1968 United Kingdom Craigavon, United Kingdom 4940 employees Grant Total: $2.00M Biopharma, Biotechnology

General Information

Company Name Almac Group
Founded Year 1968
Location United Kingdom Craigavon, United Kingdom
Employees 4940
Industries Biopharma, Biotechnology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Almac Group. To contact Almac Group, visit almacgroup.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Almac Group compare?

A PDF of Almac Group and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Almac Group soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Almac Group

Almac Group is a biotechnology, health care, and pharmaceutical company that was founded in 2002 and is headquartered in the United Kingdom. The company’s slogan, "A unique culture delivering exceptional solutions," reflects its commitment to advancing human health through its wide range of services. With a workforce of 7,000 employees globally, Almac has gained the trust of 600+ companies worldwide, including market leaders, over the past 50 years. The recent $1.00M grant investment on December 4, 2019 from the Bill & Melinda Gates Foundation further validates the quality, innovation, and efficiency of the company's business. Almac's services encompass various aspects of the pharmaceutical industry, including biomarker discovery & development, API services & chemical development, pharmaceutical development, analytical services, clinical trial supply, clinical technologies, and commercial services. This extensive range of offerings positions Almac as a comprehensive and reliable partner for companies seeking support in drug development and commercialization. The company's robust presence in the industry, demonstrated by its partnerships and investments, as well as its persistent commitment to exceptional solutions, underscores Almac Group's potential for sustained growth and impact in the biotechnology and pharmaceutical sectors. For those interested in contributing to this impactful journey, Almac provides exceptional career opportunities, inviting individuals to join its talent network for further engagement.

Business keywords: pharmaceutical development, biomarker discovery, clinical trial supply, API services, chemical development, diagnostics, companion diagnostics, analytical services, commercial manufacturing, clinical technologies, biostatistical consulting, global clinical supply chain solutions, R&D services, contract development and manufacturing, healthcare solutions

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant £2.00M 1
Innovate UK
13 Aug 2018

Almac Group Alternatives & Competitors

View All Alternatives
Almac Group vs

Sound Solution for Manufacturing

Series A
33 employees
Biopharma, Biotechnology
Almac Group vs

Your premier CDMO for biologics drug development and manufacturing, from early development, to IND,...

Series B
73 employees
Biopharma, Biotechnology
Almac Group vs

Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies

Post-IPO Secondary
33 employees
AI, Biopharma

FAQ About Almac Group

A unique culture delivering exceptional solutions
Almac Group was founded in 1968.
Almac Group is headquartered in Craigavon, United Kingdom.
Almac Group operates in Biopharma and Biotechnology. Its work centres on pharmaceutical development, biomarker discovery, clinical trial supply and API services.
Almac Group has approximately 4940 employees.
Almac Group has completed 1 funding round, raising a total of $2.00M. The latest funding stage is Grant.
Top alternatives and competitors to Almac Group include Chime Biologics, JOINN Biologics US Inc., Lantern Pharma Inc. (Nasdaq: LTRN), Celadon Pharmaceuticals, Biocon. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Almac Group and Chime Biologics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Almac Group, https://bouncewatch.com/company/almac-group, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout